Johnson and Johnson is under the microscope in India.
(SOUNDBITE) (English and Hindi) HIMACHAL PRADESH'S DRUG REGULATOR, NAVNEET MARWAH, SAYING: "After the news in the U.S., we have done an inspection to check if there is asbestos content in the talc." Regulators have already launched an investigation, and it comes after a recent Reuters report which uncovered the firm knew for decades that cancer-causing asbestos could be found in its baby powder.
This week, the country's drug authorities visited some of the company's facilities and took 'tests and samples' of its talcum powder.
Johnson and Johnson says it's fully cooperating with authorities, and claimed the visits have been mischaracterized as 'raids' - or 'seizures.'
It adds the safety of its cosmetic talc was based on a long history of safe use and decades of clinical evidence by researchers across the world.
According to the company, Indian FDAs and drug authorities have, in the past, confirmed that its products 'comply with Indian standards and are free of asbestos.'
But customers are concerned.
(SOUNDBITE) (English) CUSTOMER, NAMRATA, SAYING: "From the birth of my baby, Johnson was one product which I didn't have to rethink, I used it ever since the birth of both my kids, so that's a shocking news." A Reuters examination of internal memos and confidential documents, as well as deposition and trail testimony, showed that Johnson and Johnson's raw talc and powders sometimes tested positive for small amounts of asbestos.
It also revealed the company fretted over how to address the public while failing to disclose it to regulators or customers.
On Monday (December 17), Johnson and Johnson said it planned to buy back up to 5 billion dollars of its stock, after 40 billion was wiped from its market value following the report.